Clinical Insights from Stanford: Using TargetLOC to Navigate with Confidence
Eindhoven, the Netherlands – April 13th, 2026
Posts by Sirius Medical:
Sirius Medical Achieves MDR Certification and Expanded Indications for Pintuition® Surgical Marker Navigation
Eindhoven, the Netherlands – January 19, 2026 – Sirius Medical, the leader in surgical marker...
Sirius Medical and Mammotome Partner to Distribute Sirius Pintuition® Across Italy and Poland
Eindhoven, the Netherlands – September 30, 2025 – At Sirius Medical, we are proud to announce the...
Sirius Medical Appoints Dominic Spadafore as Strategic Advisor Role
Eindhoven, Netherlands – 7 August 2025 – Sirius Medical is pleased to announce a new strategic...
Pintuition Validated as a Safe and Reliable Navigation Solution by Large Real-World Data from the iBRA-NET study
Eindhoven, Netherlands – 7 August 2025 – Sirius Medical proudly announces positive results from...
Sirius Medical announces new Director Clinical & Medical Affairs
Sirius Medical, a medical device company that provides surgical navigation for non-palpable tumor...
Sirius Medical and Mammotome Partner to Distribute Sirius Pintuition® Across the United States and Germany
Cincinnati, Ohio, US and Eindhoven, Netherlands – February 27, 2025 - Sirius Medical, the...
Sirius Medical Secures Scale-Up Funding to Further Advance its Surgical Marker Navigation portfolio and Expand its Global Presence
Eindhoven, the Netherlands – 4 February 2025 – As World Cancer Day is observed, Dutch medical...
Elisabeth TweeSteden Hospital Reaches Milestone with 1000th Pintuition-Guided Breast-Conserving Surgery
Eindhoven, Netherlands – 8 October 2024 – The Elisabeth-TweeSteden Hospital (ETZ) in the...
Sirius Medical Launches Pintuition Slim Probe in Europe at ESSO43
Eindhoven, Netherlands – 30 September 2024 – Sirius Medical, the leader in surgical marker...